
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
George Koroneos
News & Online Content Editor
George Koroneos oversees news content for Pharmaceutical Executive Magazine as well as two e-newsletters, Pharm Exec Direct and Pharm Exec Direct Marketing Edition. Prior to joining the team, George worked for Pharm Exec's sister publication






